跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,793 条关于
“Alzheimer's Society UK”
全部
12,793
临床试验
5,181
药物
240
机构
215
资讯
7,157
去年
RI-AG03: Novel Drug Targets Tau Protein Hotspots, Showing Promise in Alzheimer's Research
去年
UK Approves Eli Lilly's Kisunla for Alzheimer's, but NHS Funding Denied
去年
Donanemab Approved in the UK, but NICE Recommends Against NHS Funding
去年
Donanemab Approved in US for Early Alzheimer's Treatment, UK Approval Uncertain
去年
Scottish Health Authority Rejects Alzheimer's Drug Donanemab Despite UK Regulatory Approval
去年
NICE Rejects First Alzheimer's Disease-Modifying Drugs for NHS Use Due to Cost-Effectiveness Concerns
去年
NICE Rejects Eli Lilly's Kisunla for Alzheimer's Despite UK Approval
去年
NHS Trials Early Dementia Detection Blood Test
9个月前
Real-World Data Shows Lecanemab Could Delay Alzheimer's Progression by 8.3 Years
去年
Donanemab Alzheimer's Drug Shows Promise But Raises Serious Safety Concerns
第 1 页,共 716 页
上一页
下一页